Skip to main
LFST

LFST Stock Forecast & Price Target

LFST Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

LifeStance Health Gr is a promising investment option, with a strong growth outlook driven by its core therapy offerings and potential expansion into specialty mental health services. Despite challenges like a rate cut from a large payer, the company's experienced management and strong financials make it an attractive investment opportunity with a projected price target of $16. However, it may face competition and other risks in the future which could impact its growth potential.

Bears say

LifeStance Health Gr is taking advantage of a rapidly expanding market opportunity in the mental healthcare sector, with potential for significant growth in its geographic footprint and services offered. However, the lack of detailed information on the company's economics and reliance on third-party vendors and physicians pose risks to its profitability. While its unique hybrid model and focus on productivity initiatives are promising, the lack of clarity on the company's future margins and earnings growth make it difficult to have a positive outlook at this time.

LFST has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LifeStance Health Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LifeStance Health Group (LFST) Forecast

Analysts have given LFST a Buy based on their latest research and market trends.

According to 8 analysts, LFST has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LifeStance Health Group (LFST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.